COVID has been beneficial to some WM patients
“COVID’s been good to me and quite a few other patients”, says Andrew Warden, who volunteered to be a “guinea pig” on a program initiated by Professor Judith Trotman.
- Non-Hodgkin lymphoma
“COVID’s been good to me and quite a few other patients”, says Andrew Warden, who volunteered to be a “guinea pig” on a program initiated by Professor Judith Trotman.
A resubmission will be considered from Kyowa Kirin for relapsed or refractory (R/R) cutaneous T-cell lymphoma.
It’s been 10 years since John Taylor’s last follow-up consultation with his haematologist.
The treatment for newly diagnosed MDS will be available “very soon” to Australians in a clinical trial.
The Australian Familial Haematological Cancer Study (AFHCS) leads the world in the field and has a research cohort of more than 200 families with a history of blood cancer.
After losing her dad to MDS, and her brother’s diagnosis just a month before hers, Christine Heath’s family underwent genomic testing to understand whether their MDS could be hereditary.
This MDS World Awareness Day, Danny Palmer will celebrate achieving remission after undergoing a life-saving transplant earlier this year. He’s now committed to raising awareness of the many different blood cancers, encouraging others to donate blood and plasma, as well as fundraise in support of the community.
Basit Salik, Dr Jamie Kuzich and Dr Julian Grabek are the successful recipients of the 2021 PhD Scholarships.
Since receiving a shock CML diagnosis in July 2020, Mel Harris has learnt quickly that the so-called ‘invisible cancer’ can have everyday impacts beyond what many would expect.
Sports-lover Oren was only the sixth child in Australia to receive CAR T-cell treatment.